Optimizing Care for EGPA: Evidence-Based Strategies for Diagnosis, Management, and Treatment

Optimizing Care for EGPA: Evidence-Based Strategies for Diagnosis, Management, and Treatment is organized by MedscapeLIVE

Release Date: 6/13/2024
Expiry Date: 6/13/2025

Description:
Patients with EGPA experience a complex and challenging journey. The rare disease is characterized by systemic vasculitis, leading to inflammation of blood vessels, often accompanied by an abnormal accumulation of eosinophils in tissues and organs. EGPA is challenging to diagnose and differentiate from other related eosinophilic disorders. This difficult disease presents healthcare providers with a challenge to effectively diagnose and provide timely interventions to prevent severe complications for patients with EGPA. In this program, a multidisciplinary expert faculty panel discusses EGPA pathophysiology, diagnostic criteria, and evidence-based management strategies to improve patient outcomes. Patient case scenarios and patient perspective video clips will illustrate challenges and management strategies for providers who treat patients with EGPA.

Upon completion of this activity, participants will be able to:

• Define the role of eosinophils and IL-5 in EGPA
• Implement evidence-based diagnostic approaches to identify EGPA
• Integrate approaches that target comorbidities, enhance quality of life, and mitigate healthcare disparities in EGPA patient care
• Utilize the current evidence and guidelines for the management and treatment of EGPA